Brigitte Charpiot

662 total citations
17 papers, 521 citations indexed

About

Brigitte Charpiot is a scholar working on Organic Chemistry, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Brigitte Charpiot has authored 17 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 7 papers in Infectious Diseases and 7 papers in Molecular Biology. Recurrent topics in Brigitte Charpiot's work include HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (4 papers) and Chemical Synthesis and Analysis (3 papers). Brigitte Charpiot is often cited by papers focused on HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (4 papers) and Chemical Synthesis and Analysis (3 papers). Brigitte Charpiot collaborates with scholars based in Austria, Switzerland and France. Brigitte Charpiot's co-authors include William B. Motherwell, Jean‐Claude Blazejewski, Derek H. R. Barton, M. Teresa Barros, D. H. R. BARTON, Stephen P. Stanforth, Jean‐Pierre Finet, David Lester, Brigitte Rosenwirth and Hubert Gstach and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Brigitte Charpiot

17 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brigitte Charpiot Austria 12 334 128 101 72 59 17 521
Donald S. Middleton United Kingdom 16 443 1.3× 187 1.5× 48 0.5× 68 0.9× 73 1.2× 45 625
Robert R. Webb United States 14 529 1.6× 249 1.9× 40 0.4× 28 0.4× 89 1.5× 26 768
Jason D. Burch Canada 14 426 1.3× 134 1.0× 35 0.3× 78 1.1× 96 1.6× 25 721
Éric Malenfant Canada 14 354 1.1× 105 0.8× 50 0.5× 82 1.1× 100 1.7× 17 521
Keith F. McDaniel United States 17 413 1.2× 281 2.2× 69 0.7× 25 0.3× 175 3.0× 37 861
Gordon G. Weingarten United Kingdom 14 411 1.2× 182 1.4× 40 0.4× 27 0.4× 78 1.3× 22 574
Richard H. Yu United States 9 392 1.2× 166 1.3× 68 0.7× 13 0.2× 37 0.6× 11 499
George V. De Lucca United States 13 375 1.1× 287 2.2× 28 0.3× 109 1.5× 169 2.9× 19 608
Hubert Gstach Austria 14 241 0.7× 323 2.5× 21 0.2× 78 1.1× 68 1.2× 57 562
Raju Penmasta United States 14 412 1.2× 125 1.0× 97 1.0× 9 0.1× 54 0.9× 29 643

Countries citing papers authored by Brigitte Charpiot

Since Specialization
Citations

This map shows the geographic impact of Brigitte Charpiot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brigitte Charpiot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brigitte Charpiot more than expected).

Fields of papers citing papers by Brigitte Charpiot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brigitte Charpiot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brigitte Charpiot. The network helps show where Brigitte Charpiot may publish in the future.

Co-authorship network of co-authors of Brigitte Charpiot

This figure shows the co-authorship network connecting the top 25 collaborators of Brigitte Charpiot. A scholar is included among the top collaborators of Brigitte Charpiot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brigitte Charpiot. Brigitte Charpiot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Charpiot, Brigitte, et al.. (2005). Competitive intelligence and patent analysis in drug discovery. Drug Discovery Today Technologies. 2(3). 211–215. 16 indexed citations
2.
Charpiot, Brigitte, Francis Bitsch, Karl‐Heinz Buchheit, et al.. (2001). Disease activated drugs: a new concept for the treatment of asthma. Bioorganic & Medicinal Chemistry. 9(7). 1793–1805. 5 indexed citations
3.
Charpiot, Brigitte, et al.. (1998). Quinazolines: Combined type 3 and 4 phosphodiesterase inhibitors. Bioorganic & Medicinal Chemistry Letters. 8(20). 2891–2896. 18 indexed citations
4.
Rabin, Linda, Mara Hincenbergs, Simon Warren, et al.. (1996). Use of standardized SCID-hu Thy/Liv mouse model for preclinical efficacy testing of anti-human immunodeficiency virus type 1 compounds. Antimicrobial Agents and Chemotherapy. 40(3). 755–762. 58 indexed citations
5.
Lehr, Philipp, Andreas Billich, Brigitte Charpiot, et al.. (1996). Inhibitors of Human Immunodeficiency Virus Type 1 Protease Containing 2-Aminobenzyl-Substituted 4-Amino-3-hydroxy-5-phenylpentanoic Acid:  Synthesis, Activity, and Oral Bioavailability. Journal of Medicinal Chemistry. 39(10). 2060–2067. 29 indexed citations
6.
Billich, Andreas, Dieter Scholz, Brigitte Charpiot, et al.. (1995). Potent and Orally Bioavailable HIV-1 Proteinase Inhibitors Containing the 2-aminobenzylstatine Moiety. Antiviral chemistry & chemotherapy. 6(5). 327–336. 7 indexed citations
7.
Billich, Andreas, Brigitte Charpiot, Gert Fricker, et al.. (1994). HIV proteinase inhibitors containing 2-aminobenzylstatine as a novel scissile bond replacement: biochemical and pharmacological characterization. Antiviral Research. 25(3-4). 215–233. 8 indexed citations
8.
Scholz, Dieter, Andreas Billich, Brigitte Charpiot, et al.. (1994). Inhibitors of HIV-1 Proteinase Containing 2-Heterosubstituted 4-Amino-3-hydroxy-5-phenylpentanoic Acid: Synthesis, Enzyme Inhibition, and Antiviral Activity. Journal of Medicinal Chemistry. 37(19). 3079–3089. 44 indexed citations
9.
Scholz, Dieter, Brigitte Charpiot, Hubert Gstach, et al.. (1993). 21 New highly potent HIV-1 protease inhibitors. Antiviral Research. 20. 52–52. 1 indexed citations
10.
Billich, Andreas, et al.. (1993). Kinetic and Binding Studies on [125I]SDZ-283471, A Radiolabeled Inhibitor of Hiv-1 Proteinase. Journal of enzyme inhibition. 7(3). 213–224. 2 indexed citations
11.
Barton, Derek H. R., Jean‐Claude Blazejewski, Brigitte Charpiot, et al.. (1985). Pentavalent organobismuth reagents. Part 2. The phenylation of phenols. Journal of the Chemical Society Perkin Transactions 1. 2657–2657. 75 indexed citations
12.
BARTON, D. H. R., Brigitte Charpiot, K. U. Ingold, et al.. (1985). Direct observation and chemistry of biradicals from photochemical decarbonylation of .alpha.-perphenylated cycloalkanones. Journal of the American Chemical Society. 107(12). 3607–3611. 33 indexed citations
13.
BARTON, D. H. R., Jean‐Claude Blazejewski, Brigitte Charpiot, et al.. (1985). Pentavalent organobismuth reagents. Part 3. Phenylation of enols and of enolate and other anions. Journal of the Chemical Society Perkin Transactions 1. 2667–2667. 77 indexed citations
14.
Barton, Derek H. R., Brigitte Charpiot, Elise Trân Huu Dâu, et al.. (1984). Structural Studies of Crystalline Pentacalent Organobismuth Compounds. Helvetica Chimica Acta. 67(2). 586–599. 41 indexed citations
15.
Barton, Derek H. R., Brigitte Charpiot, & William B. Motherwell. (1982). Regiospecific arlation by acid/base controlled reactions of tetraphenylbismuth esters. Tetrahedron Letters. 23(33). 3365–3368. 28 indexed citations
16.
Barton, Derek H. R., Jean‐Claude Blazejewski, Brigitte Charpiot, & William B. Motherwell. (1981). Tetraphenylbismuth monotrifluoroacetate: a new reagent for regioselective aryl ether formation. Journal of the Chemical Society Chemical Communications. 503–503. 30 indexed citations
17.
BARTON, D. H. R., Jean‐Claude Blazejewski, Brigitte Charpiot, et al.. (1980). Comparative arylation reactions with pentaphenylbismuth and with triphenylbismuth carbonate. Journal of the Chemical Society Chemical Communications. 827–827. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Donald S. Middleton Breakdown of academic impact, for papers by Robert R. Webb Breakdown of academic impact, for papers by Jason D. Burch Breakdown of academic impact, for papers by Éric Malenfant Breakdown of academic impact, for papers by Keith F. McDaniel Breakdown of academic impact, for papers by Gordon G. Weingarten Breakdown of academic impact, for papers by Richard H. Yu Breakdown of academic impact, for papers by George V. De Lucca Breakdown of academic impact, for papers by Hubert Gstach Breakdown of academic impact, for papers by Raju Penmasta
Rankless by CCL
2026